MedTrace Logo

Endovascular Treatment of Primary Common FEmoral Artery atheroSclerotic Disease wiTh IntraVAscular Litothripsy

NCT05821829 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-05-10

No results posted yet for this study

Summary

Prospective, nonrandomized, multicenter, national, multidisciplinary, real-world data collection with the aim to evaluate the short-term safety and efficacy of intravascular lithotripsy in the treatment of steno-obstructive disease of the common femoral artery

Conditions

  • Peripheral Arterial Disease
  • Common Femoral Artery Stenosis
  • Common Femoral Artery Occlusion
  • Critical Limb-Threatening Ischemia

Interventions

DEVICE

Intravascular litothripsy (IVL)

endovascular treatment of primary common femoral artery atherosclerotic disease with intravascular litothripsy

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-05-01
Completion
2025-05-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05821829 on ClinicalTrials.gov